• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1型糖尿病伴蛋白尿患者的血浆骨保护素浓度

Plasma osteoprotegerin concentrations in type 1 diabetic patients with albuminuria.

作者信息

Elsamahy Mona Hussein, Elhenawy Yasmine Ibrahim, Nawar Marwa Magdy

机构信息

Division of Pediatric Diabetes, Department of Pediatrics, Faculty of Medicine, Ain Shams University, Egypt.

Division of Pediatric Diabetes, Department of Pediatrics, Faculty of Medicine, Ain Shams University, Egypt.

出版信息

J Diabetes Complications. 2015 May-Jun;29(4):563-7. doi: 10.1016/j.jdiacomp.2015.02.008. Epub 2015 Feb 20.

DOI:10.1016/j.jdiacomp.2015.02.008
PMID:25744546
Abstract

BACKGROUND

Osteoprotegerin (OPG) is a recently identified inhibitor of bone resorption. Recent studies indicate that OPG is also associated with endothelial dysfunction in diabetes.

AIM

To investigate the relationship between plasma OPG levels and urinary albumin excretion (UAE) in type 1 diabetes.

METHODS

A total of 80 type 1 diabetic subjects and 40 control subjects were enrolled. Diabetic subjects were divided into a normoalbuminuric group and a microalbuminuric group according to urinary albumin excretion rate (UAER). Plasma OPG level was measured by enzyme-linked immunoassay.

RESULTS

The plasma OPG levels were significantly elevated in patients with microalbuminuria (176.39±25.05pg/ml) compared with patients with normoalbuminuria (154.73±16.66pg/ml) and control subjects (44.76±8.7pg/ml). The plasma OPG level had a positive correlation with patients' age, duration of disease, HbA1C and UAER.

CONCLUSIONS

Plasma OPG levels are significantly associated with UAE in patients with type 1 diabetes. These findings may support the concept that elevated plasma OPG may be associated with diabetic angiopathy.

摘要

背景

骨保护素(OPG)是最近发现的一种骨吸收抑制剂。近期研究表明,OPG还与糖尿病患者的内皮功能障碍有关。

目的

探讨1型糖尿病患者血浆OPG水平与尿白蛋白排泄率(UAE)之间的关系。

方法

共纳入80例1型糖尿病患者和40例对照者。根据尿白蛋白排泄率(UAER)将糖尿病患者分为正常白蛋白尿组和微量白蛋白尿组。采用酶联免疫吸附测定法检测血浆OPG水平。

结果

与正常白蛋白尿患者(154.73±16.66pg/ml)和对照者(44.76±8.7pg/ml)相比,微量白蛋白尿患者的血浆OPG水平显著升高(176.39±25.05pg/ml)。血浆OPG水平与患者年龄、病程、糖化血红蛋白(HbA1C)及UAER呈正相关。

结论

1型糖尿病患者血浆OPG水平与UAE显著相关。这些发现可能支持血浆OPG升高可能与糖尿病血管病变有关这一观点。

相似文献

1
Plasma osteoprotegerin concentrations in type 1 diabetic patients with albuminuria.1型糖尿病伴蛋白尿患者的血浆骨保护素浓度
J Diabetes Complications. 2015 May-Jun;29(4):563-7. doi: 10.1016/j.jdiacomp.2015.02.008. Epub 2015 Feb 20.
2
Increased plasma osteoprotegerin concentrations in Type 1 diabetes with albuminuria.1型糖尿病伴蛋白尿患者血浆骨保护素浓度升高。
Clin Nephrol. 2013 Mar;79(3):192-8. doi: 10.5414/CN107536.
3
Serum osteoprotegerin and tumor necrosis factor related apoptosis inducing-ligand (TRAIL) are elevated in type 2 diabetic patients with albuminuria and serum osteoprotegerin is independently associated with the severity of diabetic nephropathy.血清护骨素和肿瘤坏死因子相关凋亡诱导配体(TRAIL)在伴有白蛋白尿的 2 型糖尿病患者中升高,血清护骨素与糖尿病肾病的严重程度独立相关。
Metabolism. 2011 Aug;60(8):1064-9. doi: 10.1016/j.metabol.2010.11.002. Epub 2011 Jan 19.
4
Association between plasma osteoprotegerin concentrations and urinary albumin excretion in Type 2 diabetes.2型糖尿病患者血浆骨保护素浓度与尿白蛋白排泄之间的关联
Diabet Med. 2009 Apr;26(4):397-403. doi: 10.1111/j.1464-5491.2009.02683.x.
5
Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?血浆同型半胱氨酸与糖尿病患者的白蛋白排泄率相关:糖尿病肾病与心血管疾病之间的新联系?
Diabetologia. 1998 Jun;41(6):684-93. doi: 10.1007/s001250050969.
6
Increased plasma concentrations of osteoprotegerin in type 2 diabetic patients with microvascular complications.患有微血管并发症的2型糖尿病患者血浆骨保护素浓度升高。
Eur J Endocrinol. 2003 Jul;149(1):39-42. doi: 10.1530/eje.0.1490039.
7
The plasma osteoprotegerin level and osteoprotegerin expression in renal biopsy tissue are increased in type 2 diabetes with nephropathy.2型糖尿病肾病患者的血浆骨保护素水平及肾活检组织中的骨保护素表达均升高。
Exp Clin Endocrinol Diabetes. 2015 Feb;123(2):106-11. doi: 10.1055/s-0034-1390447. Epub 2014 Dec 12.
8
YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria.YKL-40是一种炎症和内皮功能障碍的标志物,在1型糖尿病患者中升高,并随蛋白尿水平升高而增加。
Diabetes Care. 2009 Feb;32(2):323-8. doi: 10.2337/dc08-1144. Epub 2008 Oct 28.
9
Does osteoprotegerin relate to micro- and macrovascular complications in long-term type 1 diabetes?骨保护素与长期 1 型糖尿病的微血管和大血管并发症有关吗?
Scand J Clin Lab Invest. 2010 Apr 19;70(3):188-93. doi: 10.3109/00365511003653599.
10
Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes.可溶性尿激酶型纤溶酶原激活物受体水平升高与 1 型糖尿病患者的并发症有关。
J Intern Med. 2015 Mar;277(3):362-371. doi: 10.1111/joim.12269. Epub 2014 Jun 23.

引用本文的文献

1
Elevated Serum Osteoprotegerin is Associated with Reduced Risks of Albuminuria and CKD Progression in Patients with Type 2 Diabetes.血清骨保护素升高与2型糖尿病患者白蛋白尿风险降低及慢性肾脏病进展减缓相关。
Diabetes Metab Syndr Obes. 2022 Dec 12;15:3831-3841. doi: 10.2147/DMSO.S390483. eCollection 2022.
2
Topical Reappraisal of Molecular Pharmacological Approaches to Endothelial Dysfunction in Diabetes Mellitus Angiopathy.糖尿病血管病变中内皮功能障碍的分子药理学方法的局部重新评估
Curr Issues Mol Biol. 2022 Jul 28;44(8):3378-3397. doi: 10.3390/cimb44080233.
3
Association between serum osteoprotegerin level and renal prognosis in nondialysis patients with chronic kidney disease in the Korean Cohort Study for Outcomes in Patients with Chronic Kidney Disease (the KNOW-CKD Study).
韩国慢性肾脏病患者预后队列研究(KNOW-CKD研究)中未透析慢性肾脏病患者血清骨保护素水平与肾脏预后的关联
Kidney Res Clin Pract. 2022 Mar;41(2):200-208. doi: 10.23876/j.krcp.21.173. Epub 2021 Dec 29.